Animal models of drug use have been employed for over 100 years to facilitate the 10 identification of mechanisms governing human substance use and addiction. Most 11 cross-species research on drug use/addiction examines behavioral overlap, but 12 studies assessing neuro-molecular correspondence are lacking. Our study utilized 13 transcriptome-wide data from the hippocampus and ventral tegmental area 14 (VTA)/midbrain from a total of 35 human males with cocaine use disorder/controls 15 and 49 male C57BL/6J cocaine/saline administering/exposed mice. We 16
Introduction 37
For over a hundred years animal models of drug use have provided 38 mechanistic insight into human drug addiction 1 . Most of the knowledge regarding 39 the neurobiological mechanisms contributing to human drug addiction is derived 40 from extrapolating findings from animal studies. The modus operandi for drug use in 41 animals is the self-administration paradigm (18, 865 publications between 2009-42 2019 via PubMed), in which, animals perform a behavior to consume a drug or 43 saline. Numerous variations of drug self-administration exist to model addiction 44 related behavior, but our study predominately focuses on the classic (short-access) 45 cocaine self-administration paradigm, which is considered a valid model for 46 reinforcement learning and voluntary cocaine use 2, 3 . These features seem important 47 for the development of substance abuse, but controversy remains pertaining to the 48 relationship between classic animal self-administration paradigms and human drug 49 addiction 4, 5 . 50
Generally the translational relevance for animal models of drug use is 51 investigated through a behavioral lens 6, 7 , whereby researchers assess the overlay of 52 specific animal behaviors with behavioral characteristics or clinical symptomology 53 of human drug use disorder. Such an approach is based almost entirely on face 54 validity of the animal model and the recapitulation of the highly complex aspects of 55 disordered drug use. Transcriptomic methods provide an alternate means of 56 assessing the construct validity of behavioral assays and their relevance to the study 57 of the mechanisms of human conditions. But, despite an expanding body of 58 bioinformatics data, studies investigating cross-species neuro-molecular overlap 59 have been limited -begging the question of whether, or to what degree, gene 60 expression profiles are comparable between animal models of substance use and 61 human drug use disorder. 62
Human post-mortem brain studies have produced useful information 63 regarding the molecular hallmarks associated with the "end point" of psychiatric 64 disorders 8 . While useful, these studies have many inherent limitations (for review 65 see 9 ). One pivotal drawback is determining whether human post-mortem findings 66 are specific to a trait or confounded by co-occurring illness, various technical and/or 67 biological biases. Additional complexities exist among drug use disorder research as 68 it is challenging to separate the effects of substance exposure history, drug toxicity 69 and underlying mechanism of addiction. Synchronizing gene expression from 70 precarious post-mortem human data with precise and carefully controlled studies in 71 animal models affords the opportunity to pinpoint and characterize certain neuro-72 molecular sources of variability; it may also help quantify the pathogenicity of a 73 specific behavior with a diseased state. Such insights will also inform the ongoing 74 dialogue surrounding comparative cross-species approaches in bio-behavioral 75 research 10 . 76
The current study queried extant publically available resources to identify 77 transcriptome-wide studies of animal cocaine self-administration and human 78 cocaine use disorder (CUD; DSM-IV abuse and/or dependence). We utilized data 79 from a recent cocaine use/self-administration study that assessed the 80 transcriptomic alterations in multiple reward circuitry regions in mice 11 . We 81 compared this with two post-mortem studies of individuals diagnosed with CUD 82 versus cocaine-free controls with analogous brain regions -the hippocampus 12 and 83 the midbrain/ventral tegmental area (VTA 13 ) Previous cross-species gene 84 expression studies for substance use have been limited to a single brain region and 85 typically have relied on a limited focus on candidate targets or systems [14] [15] [16] . Given 86 the etiology of substance use disorders encompasses many neurological substrates 87 and involves a multitude of molecular systems, research is warranted to examine 88 various tissues and assess global convergence across the transcriptome. 89
Additionally, genes/transcripts tend to act in a broader biological context (e.g., gene 90 co-expression networks), highlighting the importance of investigating cross-species 91 convergence for individual genes and interconnected systems of genes. 92
We hypothesized that, within meso-limbic reward circuitry 1) individual 93 genes associated with mouse cocaine self-administration would moderately 94 correspond to homologous human genes/transcripts correlated with human CUD 95 and that 2) systems (or networks) of co-expressed genes would demonstrate 96 appreciable transcriptional convergence across mice and men. 97
Materials and Methods 98

Human Samples 99
We obtained male post-mortem human hippocampal (CA4 to CA1 and 100 dentate gyrus) RNA-sequencing (RNA-seq) data from the Sequence-Read-Archive 101 (accession#: SRA029279). After outlier screening 16 The other half of midbrain samples had no history of drug or cocaine abuse and died 124 from acute causes such as cardiovascular disease or gunshot wounds. Cases and 125 controls were well matched on race and did not differ on RNA integrity (degree of 126 RNA degradation), age and brain pH level, all |t| < 1.04, all p > 0.313. 127
Mouse Samples
We utilized classic cocaine-self administration RNA-seq data from male mice 129 in two brain regions: the ventral hippocampus (n=15), and the VTA 11 (n=12; Gene 130 Expression Omnibus accession #: GSE110344). Note this sample consisted of 131 genetically homogenous C57BL/6J mice (6-8 weeks old) that had ad libitum access 132 to food and water, but restricted access to these resources during training and 133 testing. After standard food training, jugular vein catheterization surgery was 134 performed and mice recovered for 3-5 days before starting self-administration. Mice 135 were randomly assigned to either press a lever for cocaine (0.5 mg/kg/infusion; 20 136 second time-out; n=6-8 per group/brain-region) or to press a lever for saline (n=6-7 137 per group/brain-region). Over 10-15 days mice underwent 2-hour self-138 administration sessions on either a fixed-ratio one (days 5-10) or a fixed-ratio two 139 schedule (for 4-5 days). Twenty-four hours after their last self-administration 140 session mice were euthanized. 141
In addition to classic cocaine-self administration, the same study used a 142 separate/independent cohort of male C57BL/6J mice to evaluate other cocaine-143 related behaviors (see 11 for more details). Briefly, this cohort experienced classic 144 cocaine or saline self-administration, but after their last trial they experienced a 30-145 day forced abstinence period before being put in the following test conditions: 1) 146 acute cocaine or saline exposure (among saline self-administering mice; 10 mg/kg 147 intraperitoneal injection of cocaine), 2) re-exposure to only the context of cocaine or 148 saline self-administration (context re-exposure) and 3) re-exposure to cocaine or 149 saline in the context of cocaine/saline self-administration (cocaine re-exposure; 10 150 mg/kg intraperitoneal injection of cocaine). After removal of two outliers (due to low read counts), we used a total of 10-12, 9-11 and 11 mouse hippocampus and 152 VTA samples for acute cocaine exposure, context re-exposure and cocaine re-153 exposure groups, respectively. To control for age differences, these mice were 154 euthanized at the same age as the other cohort of mice and all mice experienced 155 cocaine self-administration post-puberty. This independent cohort was primarily 156 used to test the validity of gene networks constructed from the classic cocaine self-157 administration mice and was also leveraged for post-hoc comparative analyses (see 158
Supplementary Information). 159
Data Preparation 160
The current study processed RNA-seq with a unified approach. Specifically, 161
we used Trimmomattic 17 to remove Illumina adapters and low quality reads (Phred 162 score < 12). Then, utilizing the Spliced Transcripts Alignment to a Reference tool 18 163 we aligned RNA-seq data to either the human hg19 genome (Homo sapiens) or the 164 mouse mm10 genome (Mus musculus). Our RNA-seq read alignment exceeded 165 recommended thresholds 19 (all Pearson's r > 0.95) suggesting that gene expression could be collapsed across replicates. Therefore, we averaged microarray feature intensity recordings for 175 individual array ids across technical replicates for each person/individual. 176
Occasionally, multiple array ids exist for one individual gene, so we distilled array 177 ids into a single gene-level expression value via the collapseRow function in R. 178
To account for gene expression variability among individual datasets, species 179 and brain regions, we normalized data for each specific dataset separately (e.g., 180
within species and within region). Performing normalization of only overlapping 181 genes across species is thought to bias down-stream analyses 21 . Hence, we 182 normalized transcriptome-wide data using all measured genes specific to each 183 species and brain region, and consequently merged human and mouse datasets to 184 homologous genes listed from the Mouse Genome Informatics website 185 (http://www.informatics.jax.org/). Improperly accounting for differences across 186 RNA-seq and microarray platforms can also be a source of bias for bioinformatic 187 results, thus we harmonized our gene expression normalization using the voom 188 (RNA-seq) and vooma (microarray) commands. 189
Analyses 190
To identify individual genes associated with both cocaine use/self-191 administration and CUD, we compared associations across human and mouse 192 differential expression analyses. These analyses sought to minimize potential biases 193 from analytical techniques by using the same differential expression platform 194 (limma) that conducted empirical Bayes models 22 . To control for technical noise, all 195 differential expression analyses adjusted for hidden batch effects using the svaseq 196 package, which stabilizes error estimates 23 . Log fold change estimates from 197 differential expression analyses are still estimated with noise -especially for genes 198 with low baseline expression. To account for this noise, we focused our analyses on 199 differential expression t-statistics, which balance effect size and standard errors for 200 log fold change estimates, and thus, enabled us to (more confidently) characterize 201 comparative gene expression signatures transcriptome-wide. We quantified the 202 association of cross-species gene expression associations using standard linear 203 regressions and Pearson product-moment correlations. Cross-species differential 204 expression analyses included a range of 10,869 to 12,721 homologous 205 genes/transcripts. Differentially expressed genes that demonstrated associations in 206 the same direction with mouse cocaine self-administration and human CUD were 207 required to surpass a differential expression cutoff of |t| > 2. We annotated these 208 differentially expressed genes with the Kyoto Encyclopedia of Genes and Genomes 209 (KEGG; Mouse 2019) pathways using Enrichr 24 . To control for false positives, we 210 required significant KEGG pathways to survive correction for multiple testing (padj < 211 0.05) and surpass an enrichment odd's ratio (OR) > 2.00. 212
Next, we performed cross-species comparisons of gene co-expression 213 patterns. First, we created signed WGCNA gene co-expression networks 25 from 214 mouse cocaine self-administration data. For computational limitations, we filtered 215 out lowly expressed genes/transcripts (< 0.1 read count per sample), which 216 resulted in 16,029 and 15,751 genes/transcripts for WGCNA modeling in the 217 hippocampus and VTA, respectively. Using these genes/transcripts, we created a 218 correlation matrix of the expression of all WGCNA genes/transcripts with 219 themselves. We weighted these co-expression matrices by raising the correlations to a power of 12 in the hippocampus and a power of 7 in the VTA, which maximized 221 WGCNA model fit (all scale free topologies > 0.86). Our study transformed weighted 222 correlation matrices into topological overlap matrices using the TOMdist command, 223 which we converted into distance metrics (Euclidean distance) and then further 224 split into clusters of correlated genes using the hclust command. To make discrete 225 WGCNA gene networks we parsed clusters of correlated genes via a standard 226 dynamic tree-cutting algorithm (minimum network size = 50). In total, our WGCNA 227 modeling created 22 hippocampal and 19 VTA gene co-expression networks, which 228
were arbitrarily assigned to a color. 229
To test the stability, validity and conservation of these WGCNA networks, we 230 used a three-step network preservation procedure similar to Vanderlinden et al. 26 . 231 WGCNA modeling in small sample sizes may yield unstable gene networks (e.g., 232 created by chance). Therefore, to test whether mouse WGNCA networks were stable 233 and of high quality, we used a within sample technique to assess network 234 reproducibility/preservation. Specifically, we assessed the degree of network 235 preservation of WGCNA networks by comparing them to 100 bootstrapped samples 236 from the original datasets (stability). Then we quantified the validity of these 237 WGCNA gene networks. We defined validity as whether WGCNA gene networks 238 could be re-created in the same tissue and species but in an independent cohort (of 239 cocaine or saline exposed mice). Lastly, we tested the conservation of WGCNA gene 240 networks within tissue and across species. If mouse WGCNA gene networks were 241 conserved, it would suggest that co-expression patterns from self-administering 242 mice were reproducible in disordered human cocaine users and controls. As 243 recommended by Langfelder et al. 27 , all WGCNA network preservation analyses used 244
Zsummary statistics, which aggregate across seven measures of gene network 245 reproducibility. Zsummary statistics below a score of 2 indicate that networks/co-246 expression patterns are not reproducible, whereas scores between 2-10 indicate 247 weak to moderate reproducibility and Zsummary statistics above 10 are thought to be 248 highly robust 27 . 249
Since hub genes are thought to represent biologically meaningful targets in 250 disease progression 28 , we focused our analyses on hub genes from the most 251 conserved gene networks. We defined hub genes as the top 1% of most intra-252 connected network genes (e.g., the most co-expressed with all other genes in the 253 network). To better characterize the functional role of these genes in the brain we 254 performed expression-based phenome-wide association analyses (ePheWASs 29 ; 255 https://systems-genetics.org/). Specifically, these analyses investigated the 256 associations between the expression of a hub gene, in a specific brain region, with 257 1,250 unique "nervous system" traits -including both molecular and behavioral 258 phenotypes -from the BXD mouse population (consisting of inbred lines derived 259 from the progeny of a cross between C57BL/6J and DBA/2J mice). Significant 260 ePheWAS were required to survive a Bonferroni p-value correction for multiple 261 testing (p=0.05/1,250 or 0.0004). 262
Results 263
Differential Expression -Individual Genes 264
We conducted differential expression analyses within species and tissues to 265 identify specific cocaine-related genes and then quantified the degree of overlap 266 between mice and humans. The genes with increased expression in cocaine self-267 administering mice tended to also be increased in humans with CUD, in both the 268 hippocampus, b=0.076, s.e.=0.014, F(1, 12719)=29.82, p=4.823e-8, R 2 =0.0023, and 269 VTA/midbrain, b=0.042, s.e=0.001, F(1, 11856)=17.83, p=2.432e-5, R 2 =0.0014 (see Fig  270   1 ). While these associations were significant, in the expected direction and 271 reproducible across brain regions, they were modest in magnitude and only 272 accounted for ~0.1%-0.2% of the molecular variance observed in human CUD. 273
To characterize genes bolstered with cross-species support, we performed 274 functional annotation analyses of the differentially expressed genes analogously 275 associated with cocaine self-administration and CUD. Collapsing across brain 276 regions and using a t-statistic cutoff of > |2|, we found a total of 173 genes that were 277 associated with both mouse cocaine self-administration and human CUD in the same 278 direction (see Supplementary File S1). These genes were enriched for 279 thermogenesis, neurodegenerative diseases, glycolysis/gluconeogenesis, oxidative 280 phosphorylation and neurotrophin signaling (see Supplementary Table 1) . 281
Together, these results quantified the extent of transcriptional conservation and 282 disentangled the biological targets underlying mouse cocaine use and human CUD. 283
We also performed post-hoc analyses that evaluated the cross-species differential 284 expression overlap from three additional cocaine behaviors in mice: 1) acute 285 cocaine exposure, 2) context re-exposure and 3) cocaine re-exposure. But, we found 286 no replicable associations with human CUD across brain regions (see 287
Supplementary Figure S1 ). 288
Gene Co-expression Analyses -Systems of Genes
Our next step was to address the cross-species correspondence of biological 290 systems in the hippocampus and VTA/midbrain. Using mice from the classic cocaine 291 self-administration model, we created 22 data-driven WGCNA gene co-expression 292 networks in the hippocampus and 19 WGCNA gene co-expression networks in the 293 VTA. We focused our analyses on the stable (reproducible within sample) and valid 294 (preserved in an independent mouse cohort) gene co-expression networks, which 295 included 14-gene co-expression networks in the hippocampus (all Zsummary > 2.017) 296 and eight in the VTA (all Zsummary > 3.367; see Fig 2) . We investigated whether these 297 robust WGCNA networks (gene co-expression patterns) were conserved within-298 tissue and across species. In the hippocampus, only the turquoise WGCNA gene 299 network (3,218 genes) demonstrated moderate conservation in human CUD and 300 controls, Zsummary=8.793. In the mouse VTA, two gene co-expression networks 301 demonstrated weak to moderate conservation in the human midbrain: the green-302 yellow network (212 genes; Zsummary=2.631) and the blue network (3,726 genes; 303 Zsummary=6.168). 304
We selected the most conserved WGCNA gene co-expression networks per 305 brain region for follow-up investigation -the turquoise hippocampal network 306 (Supplementary File S2) and blue VTA network (Supplementary File S3). These 307 data-driven gene co-expression networks were biologically meaningful and 308 demonstrated enrichment for both shared and specific KEGG pathways including: 309 cocaine/drug addiction, neurotransmitter signaling, synaptic plasticity processes 310 and various other KEGG pathways (see Table 1 ). We further investigated the 311 overlap between the turquoise and blue gene networks and found over 2,000-shared genes across networks (see Supplementary Figure S2 ). Despite, the 313 substantial similarities in gene co-expression network structure, we found minimal 314 overlap of differentially expressed genes (p < 0.05) across the hippocampus and 315 VTA from the mouse cocaine self-administration paradigm (see Supplementary 316 Figure S3 ). Overall, these results suggest substantial transcriptional overlap across 317 brain regions at the systems level but not at the individual gene/transcript level. 318
We concentrated on hub genes for the moderately conserved turquoise and 319 blue gene co-expression networks. In total, we identified 32 and 37 hub genes for 320 the turquoise (hippocampus) and blue (VTA) gene networks, respectively. Note that 321 nine hub genes were in the top 99% of gene network intra-connectedness in both the 322 turquoise and blue gene co-expression networks, which we defined as common hub 323 genes. We visualized both the common and specific hub gene structure across 324 networks/brain regions (see Fig 3) . Our results suggest that common hub genes 325 could have an important role in multiple brain regions, but the function of these hub 326 genes in the context of cocaine use is not fully understood. 327
To investigate specific behavioral mechanisms related to the expression of 328 our common hub genes in mice, we conducted ePheWASs -first in the VTA and 329 hippocampus and subsequently in eight other brain regions, including: the 330 amygdala, cerebellum, hypothalamus, nucleus accumbens, striatum, pituitary, 331 prefrontal cortex and whole brain. In total, our common hub genes exhibited 332 eighteen significant neuro-transcriptional associations (with thirteen unique mouse 333 traits) in eight different brain regions (see Fig 4) . These results suggest that our 334 common hub genes exert a broad functional role spread across the brain (see Supplementary File S4). Most significant ePheWAS associations were molecular. 336
Slc1a2, Calm3, Aldoa, Aldoc and Eno2 were associated with dopamine and serotonin 337 function in the VTA and striatum. Additionally, we found significant ePheWAS 338 associations between Eef1a1, Aldoa and Eef1a2 with alcohol conditioned place 339 aversion 30 cocaine conditioned place preference 31 and cocaine self-administration 32 , 340 respectively. Overall, these analyses better characterize the behavioral and neuro-341 molecular role of our common hub genes within particular brain regions. 342
Discussion 343
The current study identified modest to moderate conservation of 344 transcriptional responses across mouse cocaine self-administration and human CUD 345 within reward circuitry. Specifically, we found convergent gene expression for 346 individual genes/transcripts and systems of co-expressed genes/transcripts in the 347 hippocampus and midbrain/VTA for the ubiquitous short access, intravenous 348 cocaine self-administration model. Our study is the first to quantify the extent to 349 which meso-limbic gene expression findings from mouse models of cocaine self-350 administration directly recapitulate human CUD. 351
While the correlated neuro-transcriptional response between mouse cocaine 352 self-administration and human CUD was significant, and in the expected direction, it 353 was surprisingly modest. We considered various interpretations for these 354 potentially sobering effect sizes. Inbred mice pressing a cocaine lever for two-weeks 355 and individuals with CUD have different degrees of exposure duration, use severity 356 and genetic backgrounds, which may recruit separate dimensions of biological 357 variation. Perhaps the molecular mechanisms governing reward learning are akin to 358 the development of substance use behaviors, but not necessarily tapping into the 359 core pathogenic features of the addictive process, or at least the "end state." Thus, 360 the neuro-pathophysiology of compulsive human cocaine use may be far more 361 complex than the transcriptional thumbprint of a well-controlled operant behavior. 362
Alternative models of drug use may improve cross-species prediction. Although, 363 acute cocaine exposure, context re-exposure and cocaine re-exposure models 364 tended to be less robust predictors of human CUD than the classic self-365 administration paradigm (see Supplementary Figure S1 ). 366
On the other hand, human post-mortem brain tissue may be responsible for 367 dampening cross-species effect sizes. If only a slim proportion of the observed 368 human gene expression is specific to CUD then our cross-species effects may seem 369 small but could be capturing a fair amount of disordered cocaine use variability and 370 be obfuscated by potential human confounds (co-occurring illness, cocaine toxicity 371 etc.). It is also possible that our cross-species comparisons do not follow a positive 372 linear association. For instance, during drug tolerance, neurotransmission genes 373 may demonstrate expression in one direction from short-term or acute use, but 374 exhibit compensatory expression in the opposite direction through chronic drug 375 exposure. In accordance with this, and previous cross-species research (Enoch et al. 376 2012), we found various receptor (CHRNB2, GRIN1, GLYR1) and transporter genes 377 (SLC12A3, SLC24A2, SLC35F5, SLC6A7) differentially expressed in opposing 378 directions between mouse cocaine self-administration and human CUD (all |t| > 2); 379 see Supplementary File S5). The aforementioned interpretations are not mutually 380 exclusive and, in practice, could act in a combinatorial way to mitigate cross-species 381 associations. Regardless, the current study speaks to the difficulty of modeling and 382 capturing the molecular relevance of specific animal systems for complex human 383 diseases. We rely on models as simplifications of complicated traits, to enable 384 examination of specific facets with precise experimental perturbations, but no 385 model in isolation recapitulates the daunting complexity of the human experience. 386
We extend previous cross-species drug use research 33 by investigating the 387 convergence of co-expression patterns across species in the hippocampus and 388 VTA/midbrain. While only a few of the mouse gene co-expression networks 389 surpassed the threshold of (weak to moderate) reproducibility in analogous human 390 tissues, these systems included thousands of genes. Reassuringly, we found that the 391 most conserved gene co-expression networks included numerous candidates from 392 the cocaine addiction pathway. To identify critical targets of these conserved 393 systems, we honed in on the major players (hub genes), which may regulate the 394 expression and/or function for a multitude of these genes. These genes tended to be 395 involved in broad nervous system functions, such as: synaptic plasticity (Cyfip2, Ret, 396
Tubb3, Sptbn1, Sptbn2, Spatn2), glutamate transmission (Slc1a2, Grin1, Glul) and 397 calcium signaling (Calm1, Calm2, Calm3, Atp1b1, Camkv) potentially indicating a 398 conserved and pleotropic role for more general dimensions of drug use and/or 399 addiction. Accordingly, previous research demonstrates genome-wide associations 400 of these genes with other human substance use disorder traits commonly co-morbid 401 with cocaine abuse/dependence, including: alcohol (Arhgap21 34 ), tobacco (Kif1a 35 ), 402 cannabis (Ret 36 ) and heroin (Myh10 37 ) dependence symptoms.
From the conserved VTA and hippocampus gene networks, we observed 404 nine common hub genes that may modulate brain function in multiple regions. 405
Notably, over half of these genes (Calm3, Aldoc, Clstn1, Eef1a1 and Slc1a2) were also 406 hub genes in a PFC gene network associated with human CUD that was enriched for 407 analogous KEGG pathways 38 . It is possible that common hub genes recruit similar 408 biological systems relevant to cocaine addiction across various brain regions. The 409 expression of our common hub genes were also associated with relevant traits from 410 the mouse realm -such as dopamine and serotonin function (Slc1a2, Calm3, Aldoa, 411
Aldoc and Eno2), cocaine reward and/or memory (Aldoa) and cocaine self-412 administration (Eef1a2) in the striatum, VTA, hypothalamus and cerebellum. In sum, 413 we identify and characterize critical genes from conserved biological systems 414 relevant to cocaine use and rank targets for follow-up investigation within 415 particular tissues. Of note, 64.74% of differentially expressed genes analogously 416 associated with cocaine self-administration and CUD were a part of the turquoise or 417 blue gene networks, suggesting that these complementary individual-level and 418 systems-level bioinformatics methods usurp both common and unique sources of 419 transcriptional conservation. 420
The current study has various limitations. Ascertainment of brain tissues was 421 performed in similar but not identical neurobiological substrates. That is, mouse 422 tissues were collected from the ventral hippocampus and VTA, whereas human 423 samples used tissue from the entire hippocampus and dopamine enriched regions of 424 the midbrain (VTA and substantia nigra). Another inconsistency regarding our 425 cross-species comparison is that human findings are a result of heterogeneous genetic predisposition and environmental exposure, whereas the C57BL/6J mice are 427 genetically homogenous with very controlled environmental conditions. 428
Additionally, while the current study utilized fairly small sample sizes, it is the 429 largest comparative transcriptomic human study on cocaine use to date -including 430 multiple brain regions, cocaine behaviors and analytical techniques. 431
In light of the current study, we suggest various directions for future 432 research. Relatively large post-mortem human brain samples are publically 433 available for alcohol 39 and opiates 40 and could be integrated with a multitude of 434 traits from model systems. Animal models of compulsive drug use (e.g., escalated 435 use, aversion resistant users etc.) have apparent face valid behavioral 436 correspondence to clinical symptomology of drug use disorders 41 , but whether, or to 437 what extent, these molecular mechanisms recapitulate genuine features of human 438 addiction is not known. Because there are ten times more expression studies for 439 cocaine use in animals than humans 42 , comparative neuro-transcriptomic work 440 would benefit from selecting human post-mortem brain regions that are supported 441 by the vast literature and bioinformatics database in animals (e.g., striatum/nucleus 442 accumbens). Unfortunately, the largest post-mortem human brain study on cocaine 443 was conducted in dorsal-lateral PFC neurons 43 , which seems to lack a homologous 444 substrate in the rodent brain. Heterogeneity in cell types across species can pose an 445 additional bias from cross-species comparisons 44 . Thus, a cleaner signal may emerge 446 from integrating single cell bioinformatics analyses across species. Ideally, cross-447 species research will aggregate across various layers of the transcriptome and 448 employ global integrative strategies incorporating a multitude of model systems and 449 human traits to illuminate the molecular crossroads among particular models and 450 disease processes. 451
In conclusion, this is one of the first studies to test the extent to which neuro-452 molecular correlates identified from animal models of cocaine use generalize to 453 humans diagnosed with CUD. Our analyses characterize and provided insight into 
Figure 2 Reproducibility of Gene Co-expression Networks
Barplot displaying the reproducibility/robustness of WGCNA gene co-expression networks derived from the mouse hippocampus (left) and VTA (right). Each bar represents a specific gene network -each arbitrarily assigned to a color -and constructed from cocaine self-administration mouse data. The three sections of the x-axes show whether gene networks were reproducible within sample (100 bootstrapped samples), in a separate group of cocaine/saline-exposed mice (independent cohort/same study; Walker et al. 2018) or conserved in post-mortem human CUD/controls (across species). The y-axes are the Zsummary preservation statistic values. Bars surpassing the dashed red line indicate gene networks that are highly robust and bars that exceed the dashed black line are considered weak to moderately reproducible. Note the turquoise hippocampal gene network and blue VTA gene network are highly stable/valid and are weak to moderately conserved in human tissu common and specific to the turquoise hippocampal and blue VTA gene coexpression networks. Note we highlighted in grey that the blue VTA gene network was enriched for the Cocaine Addiction KEGG pathway.
Potential Functions of Conserved Systems/Networks Across Humans and Mice
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Figure 4 Common Hub Genes Expression-based Phenome-wide Association Study (ePheWAS) of Nervous System Traits in Mice
Miami plot showing the results of our ePheWASs of common hub genes from the turquoise and blue gene networks. Each dot is a nervous system phenotype/trait (1,250 unique traits), which are color coded by hub gene (x-axis). The y-axis represents the -log10 p-value from the association of a hub gene's expression with a particular trait in a certain brain region. The top part of the plot shows results from the VTA or hippocampus and the bottom includes results from eight other cortical/sub-cortical brain regions. The dashed red line denotes the Bonferonni correction for multiple testing (0.05/1,250) and thus, all dots surpassing this threshold indicate significant associations between the expression of a gene with a trait. Note that our ePheWAS analyses utilized BXD mice, which are derived by crossing C57BL/6J and DBA/2J inbred mice. PPI = pre-pulse inhibition; CPP = conditioned place preference; CPA = conditioned place/taste aversion.
